Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
26,741
Total Claims
$2.2M
Drug Cost
1,025
Beneficiaries
$2,106
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-98%
Opioid rate vs peers
0.1% vs 2.6% avg
+97%
Cost per patient vs peers
$2,106 vs $1,068 avg
+79%
Brand preference vs peers
16.1% vs 9.0% avg
Opioid Prescribing
0.1%
Opioid Rate
17
Opioid Claims
$280
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 4,288 claims · $1.5M
Generic: 22,373 claims · $646K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 687 | $222K |
| Paliperidone Palmitate | 55 | $154K |
| Deutetrabenazine | 12 | $84K |
| Rivaroxaban | 246 | $70K |
| Valbenazine Tosylate | 17 | $65K |
| Insulin Glargine,hum.Rec.Anlog | 247 | $57K |
| Dulaglutide | 80 | $52K |
| Fluticasone/Umeclidin/Vilanter | 77 | $50K |
| Collagenase Clostridium Hist. | 55 | $48K |
| Denosumab | 27 | $46K |
| Linaclotide | 80 | $43K |
| Fluticasone/Vilanterol | 107 | $42K |
| Cannabidiol (Cbd) | 20 | $32K |
| Divalproex Sodium | 374 | $30K |
| Lipase/Protease/Amylase | 15 | $23K |
Prescribing Profile
Patient Profile
74
Avg Age
57%
Female
2.47
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data